Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Yumanity Therapeutics Inc
(NQ:
YMTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 16, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Yumanity Therapeutics Inc
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
December 05, 2022
From
Yumanity Therapeutics Inc
Via
GlobeNewswire
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
November 14, 2022
From
Yumanity Therapeutics Inc
Via
GlobeNewswire
Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.
November 10, 2022
Special Meeting of stockholders to approve asset sale and merger to be held on December 13, 2022
From
Yumanity Therapeutics Inc
Via
GlobeNewswire
YUMANITY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Yumanity Therapeutics, Inc. - YMTX
July 05, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
YUMANITY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Yumanity Therapeutics, Inc. - YMTX
June 07, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.